About PACEMAKER

Contact PACEMAKER

PACEMAKER A to Z Index

PACEMAKER Archives



   

 

PACEMAKER: Fall 2003

Trial open to patients


Chronic constipation

People with chronic constipation are invited to participate in a University of Iowa study of the effectiveness of biofeedback therapy to treat the condition. The study also will investigate quality of life and psychosocial function related to constipation problems and

treatment. Eligible participants must be 18 to 75 years old and have at least two of the following symptoms with 25 percent of their bowel movements over a three-month period: stool frequency of two or fewer times a week; hard stools; excessive straining; feeling of incomplete evacuation; feeling of blockage; or need for digital maneuvers to defecate. Compensation will be provided to eligible participants. The biofeedback technique that will be used was pioneered in large part at UI. For more information, call UI Health Access at 800-777-8442 and ask for Kara Kinkade, UI study coordinator, or call Kinkade directly at 319-384-9756, or send e-mail to kara-kinkade@uiowa.edu. Please mention having seen this article in PACEMAKER.

Pathological gambling

Some form of legalized gambling now exists in every state except Hawaii and Utah. Most adults gamble responsibly but with this proliferation, more people are developing pathological gambling--gambling that is out of control and leads to personal distress and/or marital, legal,and financial difficulties. Individuals with this problem are invited to participate in a University of Iowa Health Care study that will examine the effectiveness of the drug bupropion in treating pathological gambling. Participants must be age 18 or older and cannot be depressed or abusing alcohol or drugs. Compensation will be provided. The study, which received funding from the National Institute of Mental Health, is being led by psychiatric researcher Donald W. Black, M.D. For more information, contact UI Health Access at 800-777-8442 and ask for Kelsie Forbush, clinical trial coordinator, or call 319-353-3904, or send e-mail to forbushk@mail.medicine.uiowa.edu. Please mention having seen this article in PACEMAKER.

Prostate cancer

University of Iowa Health Care researchers invite men in their fifties and older to participate in a study of whether selenium (a mineral) or vitamin E supplements can help prevent prostate cancer. The UI is one of more than 400 sites participating in this National Cancer Institute study, which is known as SELECT (Selenium and Vitamin E Cancer Prevention Trial). Eligible men must never have had prostate cancer and be age 55 or older, or age 50 or older for African-American men. In addition, participants must not have had any other cancer (except for skin cancer) for the last five years. For more information, call the UI Cancer Information Service at 800-237-1225 or research coordinator Rhonda Wilson at 319-356-1111. Information also is available online at http://www.crab.org/select/. Please mention having seen this article in PACEMAKER.

Last modification date: Fri Dec 21 11:01:14 2007
URL: http://www.uihealthcare.com /news/pacemaker/2004/spring/opentrialtopatients.html